Study Design (S3BA3001/S3BA3002)

2 weeks

4 weeks

12 weeks

Treatment (BID)Placebo

Alosetron 1 mg

Screening

Follow-up

(No treatment)

Diarrhea-predominant

Alternating bowel pattern

Female Only

Previous slide

Next slide

Back to first slide

View graphic version